These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 10958887)
1. 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA in rat brain: pharmacological manipulation. Shirayama Y; Hashimoto K; Iyo M; Watanabe K; Higuchi T; Minabe Y Eur J Pharmacol; 2000 Aug; 402(3):215-22. PubMed ID: 10958887 [TBL] [Abstract][Full Text] [Related]
2. The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats. Mechan AO; Esteban B; O'Shea E; Elliott JM; Colado MI; Green AR Br J Pharmacol; 2002 Jan; 135(1):170-80. PubMed ID: 11786492 [TBL] [Abstract][Full Text] [Related]
3. 3,4-Methylenedioxymetamphetamine (ecstasy) induces c-fos-like protein and mRNA in rat organotypic dorsal striatal slices. Schatz DS; Kaufmann WA; Schuligoi R; Humpel C; Saria A Synapse; 2000 Apr; 36(1):75-83. PubMed ID: 10700028 [TBL] [Abstract][Full Text] [Related]
4. Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade. Ramos M; Goñi-Allo B; Aguirre N Neuropsychopharmacology; 2005 Dec; 30(12):2180-91. PubMed ID: 15841107 [TBL] [Abstract][Full Text] [Related]
5. Expression of fos protein in rat brain following administration of a nicotinic acetylcholine receptor agonist epibatidine. Watanabe K; Hashimoto K; Nishimura T; Tsunashima K; Minabe Y Brain Res; 1998 Jun; 797(1):135-42. PubMed ID: 9630573 [TBL] [Abstract][Full Text] [Related]
6. Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR. Colado MI; Granados R; O'Shea E; Esteban B; Green AR Br J Pharmacol; 1998 Jun; 124(3):479-84. PubMed ID: 9647471 [TBL] [Abstract][Full Text] [Related]
7. 3,4-Methylenedioxymethamphetamine (MDMA) enhances the release of acetylcholine by 5-HT4 and D1 receptor mechanisms in the rat prefrontal cortex. Nair SG; Gudelsky GA Synapse; 2005 Dec; 58(4):229-35. PubMed ID: 16206181 [TBL] [Abstract][Full Text] [Related]
8. Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats. Durkin S; Prendergast A; Harkin A Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1894-901. PubMed ID: 18824064 [TBL] [Abstract][Full Text] [Related]
9. MK-801 reverses Fos expression induced by the full dopamine D1 receptor agonist SKF-82958 in the rat striatum. Nakazato E; Ohno M; Watanabe S Eur J Pharmacol; 1998 Jan; 342(2-3):209-12. PubMed ID: 9548387 [TBL] [Abstract][Full Text] [Related]
10. Regulation of c-Fos and NGF1-A by antidepressant treatments. Morinobu S; Strausbaugh H; Terwilliger R; Duman RS Synapse; 1997 Apr; 25(4):313-20. PubMed ID: 9097389 [TBL] [Abstract][Full Text] [Related]
12. Caffeine-induced expression of c-fos mRNA and NGFI-A mRNA in caudate putamen and in nucleus accumbens are differentially affected by the N-methyl-D-aspartate receptor antagonist MK-801. Svenningsson P; Johansson B; Fredholm BB Brain Res Mol Brain Res; 1996 Jan; 35(1-2):183-9. PubMed ID: 8717354 [TBL] [Abstract][Full Text] [Related]
13. Induction of Fos protein by 3,4- methylenedioxymethamphetamine (Ecstasy) in rat brain: regional differences in pharmacological manipulation. Hashimoto K; Tomitaka S; Narita N; Minabe Y; Iyo M Addict Biol; 1997 Jul; 2(3):317-26. PubMed ID: 26735788 [TBL] [Abstract][Full Text] [Related]
14. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine. Colado MI; Murray TK; Green AR Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129 [TBL] [Abstract][Full Text] [Related]
15. Repeated administration of the substituted amphetamine p-methoxyamphetamine produces reductions in cortical 5-HT transporter binding but not 5-HT content, unlike 3,4-methylenedioxyamethamphetamine. Callaghan PD; Farrand K; Salem A; Hughes P; Daws LC; Irvine RJ Eur J Pharmacol; 2006 Sep; 546(1-3):74-81. PubMed ID: 16925993 [TBL] [Abstract][Full Text] [Related]
16. MK-801- and ethanol-induced activity in inbred long-sleep and short-sleep mice: dopamine and serotonin systems. Hanania T; McCreary AC; Haughey HM; Salaz DO; Zahniser NR Eur J Pharmacol; 2002 Dec; 457(2-3):125-35. PubMed ID: 12464358 [TBL] [Abstract][Full Text] [Related]
17. Effect of 5-HT depletion by MDMA on hyperthermia and Arc mRNA induction in rat brain. Beveridge TJ; Mechan AO; Sprakes M; Pei Q; Zetterstrom TS; Green AR; Elliott JM Psychopharmacology (Berl); 2004 May; 173(3-4):346-52. PubMed ID: 14735293 [TBL] [Abstract][Full Text] [Related]
18. The effects of D1 or D2 dopamine receptor blockade on zif/268 and preprodynorphin gene expression in rat forebrain following a short-term cocaine binge. Daunais JB; McGinty JF Brain Res Mol Brain Res; 1996 Jan; 35(1-2):237-48. PubMed ID: 8717360 [TBL] [Abstract][Full Text] [Related]
19. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats. Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468 [TBL] [Abstract][Full Text] [Related]
20. In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine. Colado MI; O'Shea E; Granados R; Murray TK; Green AR Br J Pharmacol; 1997 Jul; 121(5):889-900. PubMed ID: 9222545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]